Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETABI: Cognitive Biases in Ketamine Model of Psychosis
NCT02235012Phase 1Completed
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Sep 2014
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine (2 arms), sponsored by Centre Hospitalier Sainte-Anne. Primary endpoint: Evidence for biaises in decision making in an uncertain environment. Started Sep 2014; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT02235012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235012.